http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 10 Jun 2026 13:58:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++PRER14A++++MILESTONE+SCIENTIFIC+++++++++++++++++/26629212.html si-local-file:///var/storage/secattach/20260610/26629212.html http://www.streetinsider.com/SEC+Filings/Form++PRER14A++++MILESTONE+SCIENTIFIC+++++++++++++++++/26629212.html Wed, 10 Jun 2026 13:58:00 -0400 MLSS O.04998622 http://www.streetinsider.com/SEC+Filings/Form++PRER14A++++MILESTONE+SCIENTIFIC+++++++++++++++++/26629212.html si-local-file:///var/storage/secattach/20260610/26629212.html http://www.streetinsider.com/SEC+Filings/Form++PRER14A++++MILESTONE+SCIENTIFIC+++++++++++++++++/26629212.html Wed, 10 Jun 2026 13:58:00 -0400 MLSS O.04998622 http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++MILESTONE+SCIENTIFIC+++++++++++++++++/26626131.html si-local-file:///var/storage/secattach/20260610/26626131.html http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++MILESTONE+SCIENTIFIC+++++++++++++++++/26626131.html Wed, 10 Jun 2026 06:03:00 -0400 MLSS O.04998622 http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++MILESTONE+SCIENTIFIC+++++++++++++++++/26626131.html si-local-file:///var/storage/secattach/20260610/26626131.html http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++MILESTONE+SCIENTIFIC+++++++++++++++++/26626131.html Wed, 10 Jun 2026 06:03:00 -0400 MLSS O.04998622 http://www.streetinsider.com/SEC+Filings/Form++424B1++++++MILESTONE+SCIENTIFIC+++++++++++++++++/26623749.html si-local-file:///var/storage/secattach/20260609/26623749.html http://www.streetinsider.com/SEC+Filings/Form++424B1++++++MILESTONE+SCIENTIFIC+++++++++++++++++/26623749.html Tue, 09 Jun 2026 16:11:00 -0400 MLSS O.04998622 http://www.streetinsider.com/SEC+Filings/Form++424B1++++++MILESTONE+SCIENTIFIC+++++++++++++++++/26623749.html si-local-file:///var/storage/secattach/20260609/26623749.html http://www.streetinsider.com/SEC+Filings/Form++424B1++++++MILESTONE+SCIENTIFIC+++++++++++++++++/26623749.html Tue, 09 Jun 2026 16:11:00 -0400 MLSS O.04998622 http://www.streetinsider.com/SEC+Filings/Form++PRE+14A++++MILESTONE+SCIENTIFIC++++++For%3A+Jun+05/26612279.html si-local-file:///var/storage/secattach/20260605/26612279.html http://www.streetinsider.com/SEC+Filings/Form++PRE+14A++++MILESTONE+SCIENTIFIC++++++For%3A+Jun+05/26612279.html Fri, 05 Jun 2026 17:25:00 -0400 MLSS O.04998622 http://www.streetinsider.com/SEC+Filings/Form++PRE+14A++++MILESTONE+SCIENTIFIC++++++For%3A+Jun+05/26612279.html si-local-file:///var/storage/secattach/20260605/26612279.html http://www.streetinsider.com/SEC+Filings/Form++PRE+14A++++MILESTONE+SCIENTIFIC++++++For%3A+Jun+05/26612279.html Fri, 05 Jun 2026 17:25:00 -0400 MLSS O.04998622 http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++MILESTONE+SCIENTIFIC+++++++++++++++++/26592122.html si-local-file:///var/storage/secattach/20260602/26592122.html http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++MILESTONE+SCIENTIFIC+++++++++++++++++/26592122.html Tue, 02 Jun 2026 16:27:00 -0400 MLSS O.04998622 http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++MILESTONE+SCIENTIFIC+++++++++++++++++/26592122.html si-local-file:///var/storage/secattach/20260602/26592122.html http://www.streetinsider.com/SEC+Filings/Form++S-3++++++++MILESTONE+SCIENTIFIC+++++++++++++++++/26592122.html Tue, 02 Jun 2026 16:27:00 -0400 MLSS O.04998622 http://www.streetinsider.com/Analyst+Comments/Milestone+Scientific+%28MLSS%29+Reiterated+at+Speculative+Buy+by+Benchmark+After+Q1+Results/26517352.html <p>Benchmark analyst Bruce Jackson reiterated a Speculative Buy rating and $1.00 price target on Milestone Scientific (NYSE: MLSS).</p><p>The analyst commented, "Milestone Scientific hosted a 1Q business update call. Revenue of $2.2 million was roughly in line with our estimate of $2.3 million. Operating cash flow was $0.1 million for the quarter as the company showed tight expense control, ending 1Q with $1.2 million in cash. Management maintained the 2026 revenue guidance range of $9.8-10.2 million, which represents growth of more than 10% year-over-year. Within that, they expect CompuFlo revenue to grow at an even greater pace over the remainder of http://www.streetinsider.com/Analyst+Comments/Milestone+Scientific+%28MLSS%29+Reiterated+at+Speculative+Buy+by+Benchmark+After+Q1+Results/26517352.html Tue, 19 May 2026 07:45:02 -0400 MLSS http://www.streetinsider.com/Press+Releases/Milestone+Scientific+Reports+Financial+Results+for+First+Quarter+2026/26489920.html <p align="center"><em>Operating Loss Reduced As Company Advances Toward Profitability</em></p> <p align="center"><em>Reaffirms Outlook for Double-Digit Revenue Growth in 2026, including Significant Growth in CompuFlo® Sales</em></p> <p align="justify">ROSELAND, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the three months ended March 31, 2026.</p> <p align="justify">“Our first quarter results reflect continued progress as we execute on the foundation established in 2025,” said Eric Hines, Chief Executive Officer of Milestone Scientific. http://www.streetinsider.com/Press+Releases/Milestone+Scientific+Reports+Financial+Results+for+First+Quarter+2026/26489920.html Thu, 14 May 2026 07:30:00 -0400 A.30142833 MLSS O.00003102 O.04998622 http://www.streetinsider.com/Press+Releases/Milestone+Scientific+Reports+Financial+Results+for+First+Quarter+2026/26489920.html <p align="center"><em>Operating Loss Reduced As Company Advances Toward Profitability</em></p> <p align="center"><em>Reaffirms Outlook for Double-Digit Revenue Growth in 2026, including Significant Growth in CompuFlo® Sales</em></p> <p align="justify">ROSELAND, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the three months ended March 31, 2026.</p> <p align="justify">“Our first quarter results reflect continued progress as we execute on the foundation established in 2025,” said Eric Hines, Chief Executive Officer of Milestone Scientific. http://www.streetinsider.com/Press+Releases/Milestone+Scientific+Reports+Financial+Results+for+First+Quarter+2026/26489920.html Thu, 14 May 2026 07:30:00 -0400 A.30142833 MLSS O.00003102 O.04998622 http://www.streetinsider.com/Press+Releases/Milestone+Scientific+Reports+Financial+Results+for+First+Quarter+2026/26489920.html <p align="center"><em>Operating Loss Reduced As Company Advances Toward Profitability</em></p> <p align="center"><em>Reaffirms Outlook for Double-Digit Revenue Growth in 2026, including Significant Growth in CompuFlo® Sales</em></p> <p align="justify">ROSELAND, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the three months ended March 31, 2026.</p> <p align="justify">“Our first quarter results reflect continued progress as we execute on the foundation established in 2025,” said Eric Hines, Chief Executive Officer of Milestone Scientific. http://www.streetinsider.com/Press+Releases/Milestone+Scientific+Reports+Financial+Results+for+First+Quarter+2026/26489920.html Thu, 14 May 2026 07:30:00 -0400 A.30142833 MLSS O.00003102 O.04998622 http://www.streetinsider.com/Press+Releases/Milestone+Scientific+Reports+Financial+Results+for+First+Quarter+2026/26489920.html <p align="center"><em>Operating Loss Reduced As Company Advances Toward Profitability</em></p> <p align="center"><em>Reaffirms Outlook for Double-Digit Revenue Growth in 2026, including Significant Growth in CompuFlo® Sales</em></p> <p align="justify">ROSELAND, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the three months ended March 31, 2026.</p> <p align="justify">“Our first quarter results reflect continued progress as we execute on the foundation established in 2025,” said Eric Hines, Chief Executive Officer of Milestone Scientific. http://www.streetinsider.com/Press+Releases/Milestone+Scientific+Reports+Financial+Results+for+First+Quarter+2026/26489920.html Thu, 14 May 2026 07:30:00 -0400 A.30142833 MLSS O.00003102 O.04998622 http://www.streetinsider.com/Globe+Newswire/Milestone+Scientific+Reports+Financial+Results+for+First+Quarter+2026/26489920.html <p align="center"><em>Operating Loss Reduced As Company Advances Toward Profitability</em></p> <p align="center"><em>Reaffirms Outlook for Double-Digit Revenue Growth in 2026, including Significant Growth in CompuFlo® Sales</em></p> <p align="justify">ROSELAND, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the three months ended March 31, 2026.</p> <p align="justify">“Our first quarter results reflect continued progress as we execute on the foundation established in 2025,” said Eric Hines, Chief Executive Officer of Milestone Scientific. http://www.streetinsider.com/Globe+Newswire/Milestone+Scientific+Reports+Financial+Results+for+First+Quarter+2026/26489920.html Thu, 14 May 2026 07:30:00 -0400 A.30142833 MLSS O.00003102 O.04998622 http://www.streetinsider.com/Globe+Newswire/Milestone+Scientific+Reports+Financial+Results+for+First+Quarter+2026/26489920.html <p align="center"><em>Operating Loss Reduced As Company Advances Toward Profitability</em></p> <p align="center"><em>Reaffirms Outlook for Double-Digit Revenue Growth in 2026, including Significant Growth in CompuFlo® Sales</em></p> <p align="justify">ROSELAND, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the three months ended March 31, 2026.</p> <p align="justify">“Our first quarter results reflect continued progress as we execute on the foundation established in 2025,” said Eric Hines, Chief Executive Officer of Milestone Scientific. http://www.streetinsider.com/Globe+Newswire/Milestone+Scientific+Reports+Financial+Results+for+First+Quarter+2026/26489920.html Thu, 14 May 2026 07:30:00 -0400 A.30142833 MLSS O.00003102 O.04998622 http://www.streetinsider.com/Globe+Newswire/Milestone+Scientific+Reports+Financial+Results+for+First+Quarter+2026/26489920.html <p align="center"><em>Operating Loss Reduced As Company Advances Toward Profitability</em></p> <p align="center"><em>Reaffirms Outlook for Double-Digit Revenue Growth in 2026, including Significant Growth in CompuFlo® Sales</em></p> <p align="justify">ROSELAND, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the three months ended March 31, 2026.</p> <p align="justify">“Our first quarter results reflect continued progress as we execute on the foundation established in 2025,” said Eric Hines, Chief Executive Officer of Milestone Scientific. http://www.streetinsider.com/Globe+Newswire/Milestone+Scientific+Reports+Financial+Results+for+First+Quarter+2026/26489920.html Thu, 14 May 2026 07:30:00 -0400 A.30142833 MLSS O.00003102 O.04998622 http://www.streetinsider.com/Globe+Newswire/Milestone+Scientific+Reports+Financial+Results+for+First+Quarter+2026/26489920.html <p align="center"><em>Operating Loss Reduced As Company Advances Toward Profitability</em></p> <p align="center"><em>Reaffirms Outlook for Double-Digit Revenue Growth in 2026, including Significant Growth in CompuFlo® Sales</em></p> <p align="justify">ROSELAND, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the three months ended March 31, 2026.</p> <p align="justify">“Our first quarter results reflect continued progress as we execute on the foundation established in 2025,” said Eric Hines, Chief Executive Officer of Milestone Scientific. http://www.streetinsider.com/Globe+Newswire/Milestone+Scientific+Reports+Financial+Results+for+First+Quarter+2026/26489920.html Thu, 14 May 2026 07:30:00 -0400 A.30142833 MLSS O.00003102 O.04998622 http://www.streetinsider.com/Earnings/Milestone+Scientific+%28MLSS%29+Tops+Q1+EPS+by+1c/26489878.html <p>Milestone Scientific (NYSE: MLSS) reported Q1 EPS of ($0.01), $0.01 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $2.16 million versus the consensus estimate of $2.35 million.</p><p>For earnings history and earnings-related data on Milestone Scientific (MLSS) <a href="http://www.streetinsider.com/ec_earnings.php?q=MLSS">click here</a>.</p> http://www.streetinsider.com/Earnings/Milestone+Scientific+%28MLSS%29+Tops+Q1+EPS+by+1c/26489878.html Thu, 14 May 2026 07:26:15 -0400 MLSS http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++MILESTONE+SCIENTIFIC++++++For%3A+Mar+31/26485681.html si-local-file:///var/storage/secattach/20260513/26485681.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++MILESTONE+SCIENTIFIC++++++For%3A+Mar+31/26485681.html Wed, 13 May 2026 16:01:00 -0400 MLSS O.04998622 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++MILESTONE+SCIENTIFIC++++++For%3A+Mar+31/26485681.html si-local-file:///var/storage/secattach/20260513/26485681.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++MILESTONE+SCIENTIFIC++++++For%3A+Mar+31/26485681.html Wed, 13 May 2026 16:01:00 -0400 MLSS O.04998622 http://www.streetinsider.com/Press+Releases/Milestone+Scientific+Schedules+First+Quarter+2026+Financial+Results+and+Business+Update+Conference+Call/26453152.html <p align="left">ROSELAND, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- <strong>Milestone Scientific Inc. (NYSE: MLSS)</strong>, a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced that it will host a conference call at 8:30 AM Eastern Time on Thursday, May 14, 2026, to discuss the company’s financial results for the first quarter ended March 31, 2026, as well as the company’s corporate progress and other developments.</p> <p align="left">The conference call will be available via telephone by dialing toll free 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and by entering the http://www.streetinsider.com/Press+Releases/Milestone+Scientific+Schedules+First+Quarter+2026+Financial+Results+and+Business+Update+Conference+Call/26453152.html Thu, 07 May 2026 16:10:00 -0400 MLSS http://www.streetinsider.com/Globe+Newswire/Milestone+Scientific+Schedules+First+Quarter+2026+Financial+Results+and+Business+Update+Conference+Call/26453152.html <p align="left">ROSELAND, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- <strong>Milestone Scientific Inc. (NYSE: MLSS)</strong>, a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced that it will host a conference call at 8:30 AM Eastern Time on Thursday, May 14, 2026, to discuss the company’s financial results for the first quarter ended March 31, 2026, as well as the company’s corporate progress and other developments.</p> <p align="left">The conference call will be available via telephone by dialing toll free 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and by entering the http://www.streetinsider.com/Globe+Newswire/Milestone+Scientific+Schedules+First+Quarter+2026+Financial+Results+and+Business+Update+Conference+Call/26453152.html Thu, 07 May 2026 16:10:00 -0400 MLSS http://www.streetinsider.com/Press+Releases/Milestone+Scientific+Expands+CompuFlo%C2%AE+Medical+Business+with+Advisor+Program+and+Growing+National+Clinical+Adoption/26449121.html <p align="left">ROSELAND, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments, today provided an update on the expansion of its CompuFlo® medical business, highlighting increasing physician utilization, expanding clinical engagement, and continued development of its commercial and reimbursement infrastructure.</p> <p align="left"><strong>Advisor Program Driving Utilization and Real-World Data Generation</strong></p> <p align="left">Since launching the CompuFlo® Advisor Program in February 2026, the Company has onboarded physician advisors and initiated procedural use across key Medicare Administrative Contractor (MAC) jurisdictions, including Novitas, First Coast Service Options, and Palmetto, as well http://www.streetinsider.com/Press+Releases/Milestone+Scientific+Expands+CompuFlo%C2%AE+Medical+Business+with+Advisor+Program+and+Growing+National+Clinical+Adoption/26449121.html Thu, 07 May 2026 08:30:00 -0400 A.11344126 A.27364895 A.28110669 A.30142833 MLSS O.00003102 O.00038757 O.03956383 O.04998622 O.48401414